Cover Image
市場調查報告書

全球產前·新生兒遺傳基因檢驗市場

Global Prenatal and Newborn Genetic Testing Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 322258
出版日期 內容資訊 英文 70 Pages
訂單完成後即時交付
價格
Back to Top
全球產前·新生兒遺傳基因檢驗市場 Global Prenatal and Newborn Genetic Testing Market 2015-2019
出版日期: 2014年12月31日 內容資訊: 英文 70 Pages
簡介

產前·新生兒遺傳基因檢驗包含產前產後的遺傳基因檢驗。產前檢查可檢測出出生前胎兒的變化。全球產前·新生兒遺傳基因檢驗市場預測2014年∼2019年的年複合成長率將為31.91%。

本報告提供全球產前·新生兒遺傳基因檢驗市場相關調查分析,提供您市場規模與成長率,市場趨勢,推動市場要素·課題,市場機會相關驗証,以及主要供應商等相關的系統性資訊。

第1章 摘要整理

第2章 簡稱清單

第3章 調查範圍

  • 市場概要
  • 主要的產品

第4章 市場調查手法

  • 市場調查流程
  • 調查手法

第5章 簡介

第6章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 市場區隔:各技術

第8章 產前篩檢檢驗

第9章 原因和危險因素

第10章 產前的遺傳性疾病

第11章 地區區分

第12章 購買標準

第13章 推動市場成長要素

第14章 推動因素與其影響

第15章 市場課題

第16章 推動因素與課題的影響

第17章 市場趨勢

第18章 趨勢與其影響

第19章 業者情勢

  • 競爭模式
  • 市場佔有率分析
  • 其他卓越供應商

第20章 主要供應商分析

  • Agilent Technologies
  • Bio-Rad Laboratories
  • Sequenom
  • Illumina

第21章 相關報告

圖表

目錄
Product Code: IRTNTR4941

About Prenatal and Newborn Genetic Testing

Prenatal and newborn genetic testing involves genetic testing before and after birth. Prenatal testing helps detect changes in the fetus before birth. It can reduce a couple's uncertainty or help them decide whether to abort a pregnancy in case of conditions such as Down syndrome, trisomy 18, or an open neural tube defect. The procedure includes two blood tests: one in the first trimester and the next in the second trimester. On the other hand, newborn genetic testing is done just after birth to identify genetic disorders.

TechNavio's analysts forecast the Global Prenatal and Newborn Genetic Testing market to grow at a CAGR of 31.91 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Prenatal and Newborn Genetic Testing market for the period 2015-2019. The Global Prenatal and Newborn Genetic Testing market can be divided into two segments: Diagnostic Techniques and Screening Methods. To calculate the market size, the report considers revenue generated from these segments.

TechNavio's report, the Global Prenatal and Newborn Genetic Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Prenatal and Newborn Genetic Testing market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Agilent Technologies
  • Bio-Rad Laboratories
  • Illumina
  • Sequenom

Market Driver

  • Growing Incidences of Fetal Health-related Abnormalities
  • For a full, detailed list, view our report

Market Challenge

  • Decrease in Fertility Rates
  • For a full, detailed list, view our report

Market Trend

  • Increase in Number of New Product Launches
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Technology

08. Prenatal Screening Tests

09. Causes and Risk Factors

10. Genetic Disorders before Birth

11. Geographical Segmentation

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape

  • 19.1. Competitive Scenario
    • 19.1.1. Key News
    • 19.1.2. Mergers and Acquisitions
  • 19.2. Market Share Analysis 2014
  • 19.3. Other Prominent Vendors

20. Key Vendor Analysis

  • 20.1. Agilent Technologies
    • 20.1.1. Key Facts
    • 20.1.2. Business Overview
    • 20.1.3. Business Segmentation by Revenue 2013
    • 20.1.4. Product Portfolio by Revenue 2013
    • 20.1.5. Business Segmentation by Revenue 2012 and 2013
    • 20.1.6. Geographical Segmentation by Revenue 2013
    • 20.1.7. Business Strategy
    • 20.1.8. Recent Developments
    • 20.1.9. SWOT Analysis
  • 20.2. Bio-Rad Laboratories
    • 20.2.1. Key Facts
    • 20.2.2. Business Overview
    • 20.2.3. Business Segmentation by Revenue 2013
    • 20.2.4. Product Portfolio by Revenue 2013
    • 20.2.5. Business Segmentation by Revenue 2012 and 2013
    • 20.2.6. Geographical Segmentation by Revenue 2013
    • 20.2.7. Business Strategy
    • 20.2.8. Recent Developments
    • 20.2.9. SWOT Analysis
  • 20.3. Sequenom
    • 20.3.1. Key Facts
    • 20.3.2. Business Overview
    • 20.3.3. Business Segmentation by Revenue 2013
    • 20.3.4. Product Portfolio by Revenue 2013
    • 20.3.5. Business Segmentation by Revenue 2012 and 2013
    • 20.3.6. Geographical Segmentation by Revenue 2013
    • 20.3.7. Business Strategy
    • 20.3.8. Recent Developments
    • 20.3.9. SWOT Analysis
  • 20.4. Illumina
    • 20.4.1. Key Facts
    • 20.4.2. Business Overview
    • 20.4.3. Business Segmentation by Revenue 2013
    • 20.4.4. Product Portfolio by Revenue 2013
    • 20.4.5. Business Segmentation by Revenue 2012 and 2013
    • 20.4.6. Geographical Segmentation by Revenue 2013
    • 20.4.7. Business Strategy
    • 20.4.8. Recent Developments
    • 20.4.9. SWOT Analysis

21. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Prenatal and New-born Genetic Testing Market 2014-2019 (US$ billion)
  • Exhibit 3: Global Prenatal and New-born Genetic Testing market Segmentation by Technology
  • Exhibit 5: Global Prenatal and New-born Genetic Testing Market Segmentation by Technology
  • Exhibit 6: Global Prenatal and New-born Genetic Testing Market Segmentation by Type of Test
  • Exhibit 7: Global Diagnostic Techniques Market Segmentation by Type of Test
  • Exhibit 8: Global Screening Methods Market Segmentation by Type of Test
  • Exhibit 9: Causes and Risk Factors of Prenatal and New-born Genetic Testing
  • Exhibit 10: Various Genetic Disorders before Birth
  • Exhibit 11: Global Prenatal and New-born Genetic Testing Market by Geographical Segmentation 2014
  • Exhibit 12: Global Incidence of Chromosomal Abnormalities in New-borns
  • Exhibit 13: Declining Fertility Rates
  • Exhibit 14: Spontaneous Abortions and Fertility Rates as a Function of Maternal Age
  • Exhibit 15: Risks of Down Syndrome and Chromosomal Abnormalities at Live Birth, According to Maternal Age
  • Exhibit 16: Agilent Technologies: Business Segmentation by Revenue 2013
  • Exhibit 17: Agilent Technologies: Business Segmentation by Revenue 2012 and 2013
  • Exhibit 18: Agilent Technologies: Sales by Geography 2013
  • Exhibit 19: Bio-Rad Laboratories: Business Segmentation by Revenue 2013
  • Exhibit 20: Bio-Rad Laboratories: Business Segmentation by Revenue 2012 and 2013
  • Exhibit 21: Bio-Rad Laboratories: Sales by Geography 2013
  • Exhibit 22: Sequenom: Business Segmentation by Revenue 2013
  • Exhibit 23: Sequenom: Business Segmentation by Revenue 2012 and 2013
  • Exhibit 24: Sequenom: Sales by Geography 2013
  • Exhibit 25: Illumina: Business Segmentation by Revenue 2013
  • Exhibit 26: Illumina: Business Segmentation by Revenue 2012 and 2013
  • Exhibit 27: Illumina: Sales by Geography 2013
Back to Top